• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B.BRAUN SURGICAL SA OPTILENE 5/0 (1) 90CM 2XHR22 CV RCP; SUTURES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B.BRAUN SURGICAL SA OPTILENE 5/0 (1) 90CM 2XHR22 CV RCP; SUTURES Back to Search Results
Model Number G3090975
Device Problems Break (1069); Material Integrity Problem (2978); Material Twisted/Bent (2981)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/01/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Manufacturing site evaluation: evaluation on-going.
 
Event Description
Country of complaint: (b)(6).It is reported that the thread breaks easily and the needle is bent.
 
Manufacturer Narrative
Samples received: 1 unopened racepack.Analysis and results: there are no previous complaints of this code-batch.We manufactured and distributed in the market 540 units of this code-batch.There are no units in our stock.We have received 1 closed sample to analyze this complaint.We have tested the knot pull tensile strength of the sample received and the result fulfils the requirements of the european pharmacopoeia (ep): xi= 0.79 kgf (ep requirements: 0.31 kgf in average and 0.10 kgf in minimum).Remarks: "when working with optilene® suture material, great care should be taken to avoid any crushing or crimping damage of the monofilament by instruments such as forceps or needle holders".On the other hand, the needles of the sample received (reference with double needle) have been tested for bending strength and the results fulfill product specifications: 3.63 nxcm and 3.82 nxcm in minimum.Minimum bending strength specification: > 3.1 nxcm.Remarks: care should be taken to avoid damage when handling surgical needles.Grasp the needle in an area one-third (1/3) to one-half (1/2) of the distance from the attachment end to the point.Grasping in the point area could impair the penetration performance and cause fracture of the needle.Grasping at the butt or attachment end could cause bending or breakage.Reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfil usp/ep and b.Braun surgical requirements.Final conclusion: although the results of the sample received fulfil the specifications of european pharmacopoeia/ b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTILENE 5/0 (1) 90CM 2XHR22 CV RCP
Type of Device
SUTURES
Manufacturer (Section D)
B.BRAUN SURGICAL SA
121 carretera de terrassa
rubi, 08191
SP  08191
MDR Report Key7688053
MDR Text Key114030978
Report Number3003639970-2018-00402
Device Sequence Number1
Product Code GAW
Combination Product (y/n)N
PMA/PMN Number
K133890
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/19/2021
Device Model NumberG3090975
Device Catalogue NumberG3090975
Device Lot Number116075
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/25/2018
Distributor Facility Aware Date06/25/2018
Initial Date Manufacturer Received 06/14/2018
Initial Date FDA Received07/13/2018
Supplement Dates Manufacturer Received06/14/2018
Supplement Dates FDA Received07/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-